Induction immunosuppressive therapy in the elderly kidney transplant recipient in the United States
about
Renal transplantation with expanded criteria donors: Which is the optimal immunosuppression?Selection of induction therapy in kidney transplantationA Rationale for Age-Adapted Immunosuppression in Organ TransplantationSolid-organ transplantation in older adults: current status and future researchPoor outcomes in elderly kidney transplant recipients receiving alemtuzumab induction.Induction therapy in renal transplant recipients: a review.Clinical issues in renal transplantation in the elderly.Comparing Outcomes between Antibody Induction Therapies in Kidney Transplantation.Cost-Effectiveness of Antibody-Based Induction Therapy in Deceased Donor Kidney Transplantation in the United States.How does age affect the outcome of kidney transplantation in elderly recipients?National Variation in Use of Immunosuppression for Kidney Transplantation: A Call for Evidence-Based Regimen Selection.Induction therapy: clinical and quality of life outcomes in aged renal transplant recipients.How immunosuppressive therapy affects T cells from kidney transplanted patients of different age: the role of latent cytomegalovirus infection.Managing transplant rejection in the elderly: the benefits of less aggressive immunosuppressive regimens.Prediction of three-year outcome of renal transplantation from optimal donors versus expanded criteria donorsManaging End-Stage Renal Disease in Older Patients: A Single Centre Experience with Renal Transplantation in the Elderly
P2860
Q26751461-00C7FB13-F44E-46F7-8DEF-70FBA31F28FAQ26864234-E7335776-EEB5-4EAF-8090-04E6B8003E46Q28080954-44A9A699-07BE-41CF-BCF2-9A83F5A5D6FAQ28727427-324057BA-FE98-40F7-9905-E200A25CE56CQ35611179-F3D116EC-F3D2-4D72-9538-6C77654E156BQ38258154-76E76A56-B622-4890-B49C-315664AF43DCQ38265828-131F8867-AA31-4120-88DC-8C84D3A6F485Q38892578-B626219C-8948-4BA0-92D9-2AF5D9674B6CQ39630797-2B045C64-8E94-499B-84E1-B754773AC507Q40162118-A255ADEE-A7EF-4F52-919E-317905735909Q41036267-D1C7B182-FED2-4AB4-BA6C-AB8923E80B3BQ41564371-0A8DEE92-9069-4711-B439-67661A469329Q42270266-85BDDA83-8851-4D21-8F62-39F2A00AD045Q45078004-C314E92F-6666-47A8-B24D-B2A795C5A678Q56979309-8D592AC5-F89C-4AEF-9356-275D6051BEBFQ59049763-6A885324-0F98-46A6-A012-818C6921116F
P2860
Induction immunosuppressive therapy in the elderly kidney transplant recipient in the United States
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Induction immunosuppressive th ...... recipient in the United States
@ast
Induction immunosuppressive th ...... recipient in the United States
@en
Induction immunosuppressive th ...... recipient in the United States
@nl
type
label
Induction immunosuppressive th ...... recipient in the United States
@ast
Induction immunosuppressive th ...... recipient in the United States
@en
Induction immunosuppressive th ...... recipient in the United States
@nl
prefLabel
Induction immunosuppressive th ...... recipient in the United States
@ast
Induction immunosuppressive th ...... recipient in the United States
@en
Induction immunosuppressive th ...... recipient in the United States
@nl
P2093
P2860
P356
P1476
Induction immunosuppressive th ...... recipient in the United States
@en
P2093
Gabriel M Danovitch
Hung-Tien Kuo
Jagbir Gill
James Dong
John S Gill
Marcelo Sampaio
Suphamai Bunnapradist
P2860
P304
P356
10.2215/CJN.07540810
P407
P577
2011-05-01T00:00:00Z